Table 2. Time of onset of symptoms*.
| Post-COVID-19 (symptoms ≥12 weeks after infection) | ||||
| Not hospitalized n = 588 | Hospitalized n = 127 | |||
| Immediate onset n (%) | Delayed onset n (%) | Immediate onset n (%) | Delayed onset n (%) | |
| Fever | 4 (0.7) | 0 (0) | 0 (0) | 0 (0) |
| Diarrhea/vomiting | 8 (1.3) | 3 (0.5) | 4 (3.1) | 1 (0.8) |
| Sore throat | 15 (2.6) | 0 (0) | 5 (3.9) | 1 (0.8) |
| Rhinitis or rhinorrhea | 23 (3.9) | 1 (0.2) | 6 (4.7) | 0 (0) |
| Skin lesions | 12 (2.0) | 14 (2.3) | 6 (4.7) | 9 (7.0) |
| Headache | 45 (7,7) | 11 (1.9) | 7 (5.5) | 2 (1.6) |
| Mucosal dryness | 36 (6.1) | 13 (2.2) | 10 (7.8) | 5 (3.9) |
| Coughing | 51 (8.7) | 6 (1.0) | 19 (15.0) | 2 (1.6) |
| Palpitations | 32 (5.4) | 27 (4.6) | 21 (16.5) | 7 (5.5) |
| Vertigo | 42 (7.1) | 22 (3.7) | 24 (18.9) | 11 (8.7) |
| Depression or sadness | 38 (6.4) | 36 (6.1) | 24 (18.9) | 14 (11.0) |
| Other mental disorders | 72 (12.2) | 50 (8.5) | 30 (23.6) | 15 (11.8) |
| Myalgia or arthralgia | 65 (11.0) | 13 (2.2) | 25 (19.7) | 10 (7.8) |
| Hair loss | 17 (2.9) | 54 (9.2) | 14 (11.0) | 28 (22.0) |
| Dyspnea | 60 (10.2) | 42 (7.1) | 29 (22.8) | 5 (3.9) |
| Loss of taste | 133 (22.6) | 29 (4.9) | 16 (12.5) | 7 (5.5) |
| Loss of smell | 124 (21.1) | 35 (5.9) | 20 (15.7) | 3 (2.3) |
| Difficulty concentrating | 95 (16.1) | 68 (11.6) | 44 (34.6) | 12 (9.4) |
| Fatigue or lethargy | 174 (29.6) | 41 (7.0) | 68 (53.5) | 11 (8.6) |
| Rapid physical exhaustion | 170 (28.9) | 35 (5.9) | 72 (56.7) | 11 (8.6) |
*Symptoms with immediate onset (within 2 weeks of infection) or late onset (at least 2 weeks after infection) in non-hospitalized and hospitalized participants with symptoms persisting for at least 12 weeks (post-COVID-19).